FDA Adverse Event Malfunction Summary report: N

LIGAMAX-5MM ENDO CLIP APPLIER

MDR report key: 1811604 · Received August 23, 2010

Report

Report Number
3005075853-2010-04785
Event Type
Malfunction
Date Received
August 23, 2010
Date of Event
July 27, 2010
Report Date
July 28, 2010
Manufacturer
ETHICON ENDO-SURGERY, LLC.
Product Code
FZP
PMA / PMN Number
K050344
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

(B)(4). INFORMATION ANTICIPATED, BUT UNAVAILABLE AT THIS TIME.

Additional Manufacturer Narrative · 1

(B)(4). BROKEN JAW AT BIFURCATION THE ANALYSIS RESULTS FOUND THAT THE DEVICE WAS RECEIVED WITH THE JAWS BROKEN AT BIFURCATION AND WITH EXCESSIVE DRIED BODY FLUIDS. IN ORDER TO EVALUATE THE DEVICE'S INTERNAL COMPONENTS THE DEVICE WAS DISASSEMBLED. UPON DISASSEMBLING OF THE DEVICE EVIDENCES OF CORROSION ON THE BREAK AREA WERE NOTED. THE MOST LIKELY REASON FOR JAW BIFURCATION BREAKAGE IS STRESS CORROSION CRACKING AND THE MOST LIKELY ROOT CAUSE IS EXPOSURE TO A SOLUTION CONTAINING CHLORINE. THIS CONDITION IS VERY UNLIKELY TO OCCUR DURING A SURGICAL PROCEDURE AND IS MOST LIKELY TO OCCUR AFTER POST-SURGERY DEVICE CLEANING. THE JAW BREAKAGE IS NOT OCCURRING AS A RESULT OF THE PRODUCT COMPLAINT DECONTAMINATION PROCESS. DUE TO THE CONDITION OF THE DEVICE, NO FUNCTIONAL TESTING COULD BE PERFORMED TO EVALUATE THE REPORTED INCIDENT. THE BATCH RECORD WAS REVIEWED AND NO ANOMALIES WERE NOTED DURING THE MANUFACTURING PROCESS.

Description of Event or Problem · 1

IT WAS REPORTED THAT DURING A LAPAROSCOPIC SIGMOIDECTOMY PROCEDURE, THE JAW BECAME NOT TO OPEN AFTER THE DEVICE WAS FIRED ON THE BLOOD VESSEL. ANOTHER DEVICE WAS USED TO COMPLETE THE PROCEDURE. THERE WERE NO ADVERSE CONSEQUENCES FOR THE PATIENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 LIGAMAX-5MM ENDO CLIP APPLIER CLIP, IMPLANTABLE FZP ETHICON ENDO-SURGERY, LLC. NA G4RP6R

Patients

Seq Age Sex Outcome Treatment
1